Medtronic reported Q3 earnings per share of $1.45, surpassing estimates of $1.39, and revenue of $9.76 billion, above the $9.55 billion consensus. The strong financial results reflect broad demand for its cardiovascular devices. The company raised its full-year financial outlook, signaling confidence in continued growth. Medtronic is investing over $700 million in innovative platforms like Heart Tech and Robotics, including a new robot surgeon, to drive future technological advancements and growth.
Medtronic announced a 13.7% increase in revenue to $9.8 billion for Q1 of fiscal year 2027, driven by strong growth across cardiovascular, neuroscience, and medical surgical segments. The company raised its full-year organic revenue growth guidance t...
Medtronic has made a strategic investment of up to $80 million in Pi-Cardia, a company specializing in leaflet modification technologies for structural heart disease. This investment supports Medtronic's goal to enhance its structural heart portfolio...
Despite two major recessions in the past two decades, four healthcare companies—Johnson & Johnson, Abbott Laboratories, Medtronic, and Becton Dickinson—consistently raised their dividends each quarter. Their strong cash flows and inelastic demand for...
The August jobs report is crucial for the Federal Reserve's decision on a potential September rate hike, with strong labor data increasing the odds. Broadcom faces downside risk ahead of earnings due to high AI expectations, while Apple transitions t...
